Indian official disputes Novartis chief’s patent complaints

Tracy Staton Novartis CEO Joe Jimenez wrote to Indian Commerce and Industry Minister Anand Sharma, accusing the government of favoring domestic companies over multinationals in its ...

USPTO Issues Initial Action on Reexamination of Cadence Pharmaceuticals Patent

mia.burns Cadence Pharmaceuticals Comments on USPTO’s Non-Final, Initial Office Action on Reexamination of Patent SAN DIEGO, Aug. 15, 2013 /PRNewswire/ — Cadence Pharmaceuticals, ...

Verastem Issued U.S. Patent Covering VS-4718 Composition of Matter

barbara.lempert CAMBRIDGE, MA – Aug. 15, 2013 – Verastem, Inc. (NASDAQ: VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer ...

Avanir, Sandoz Settle Nuedexta Patent Suit

barbara.lempert Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Sandoz ALISO VIEJO, Calif., Aug. 14, 2013 /PRNewswire/ — Avanir Pharmaceuticals, ...

Medicines Patent Pool Is ‘Taken Seriously’ Now: Perry Explains

esilverman Last week, the Medicines Patent Pool struck its second deal in less than six months with a big drugmaker. The agreements marked a decided turnabout for the foundation, ...

Aegis Awarded 3rd Patent for Fast Acting Migraine Nasal Spray Treatment

barbara.lempert Aegis’ Intravail® formulation of sumatriptan achieves therapeutic drug levels in approximately 2 to 3 minutes SAN DIEGO, CA Aug 13, 2013 — Aegis Therapeutics ...

R&D talent cluster locations drive life science U.S. patent approvals

mia.burns By Mia Burns Innovation is more necessary than ever in the United States’ post-patent-cliff market, as chronicled in the annual Jones Lang LaSalle Life Sciences Cluster ...

South Africa Urged To Overhaul Patent Laws To Boost Access To Meds

esilverman As South Africa holds a meeting today with officials from the World Health Organization and World Trade Organization to review intellectual property protection, ...

China revokes patent on Gilead’s Viread

Eric Palmer In another swipe at the intellectual property of drugmakers in emerging markets, China's State Intellectual Property Office (SIPO) has yanked the patent for Viread, ...

Despite India’s Herceptin patent moves, biosimilar rival isn’t imminent

Tracy Staton Don't panic on Roche's behalf yet. Losing some Herceptin patent protections in India doesn't mean biosimilar versions will hit the market posthaste. That's ...

China Revokes Patent On Gilead AIDS Drug Over Pricing

esilverman In the latest row between global drugmakers and governments over affordable medicines, China’s State Intellectual Property Office revoked the patent on Viread, ...

Roche throws HIV blindness drug Valcyte into patent pool

Carly Helfand Roche has signed an agreement with the Medicines Patent Pool to surrender Valcyte's patent and make the drug available in developing countries by slashing costs by ...
Page 3 of 612345...Last »
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS